# Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic Metastases

> **NCT04973007** · PHASE4 · TERMINATED · sponsor: **University of Colorado, Denver** · enrollment: 10 (actual)

## Conditions studied

- Oligometastatic Disease
- Liver Metastases
- Colorectal Cancer

## Interventions

- **DRUG:** Gadoxetate disodium
- **DRUG:** Gadobenate dimeglumine

## Key facts

- **NCT ID:** NCT04973007
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-06-22
- **Primary completion:** 2025-05-06
- **Final completion:** 2025-05-08
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Low Accrual
- **Last updated:** 2026-04-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04973007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04973007, "Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic Metastases". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04973007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*